Pentobarbital decreases effects of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Carefully. Coadministration of CYP3A4 inducers could reduce sufentanil levels and efficacy, probably precipitating withdrawal syndrome in sufferers who may have developed Actual physical dependence to sufentanil. Discontinuation of concomitantly utilised CYP3... https://sodium-pentobarbital-effe85050.nizarblog.com/22409076/not-known-details-about-sodium-pentobarbital-in-humans